Airbnb CEO says one-on-one meetings are often a missed opportunity for collaborative learning
“The one-on-one model is flawed. It’s a recurring one-hour one-on-one meeting where the employee owns the agenda. And what ...
Yahoo Finance15 小时
Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan ...
18, 2024 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneer of AAV immuno-gene therapy for cancer, today revealed its lead ...
EuropaWire19 小时
Barco Unveils Cutting-Edge Simulation Projectors at I/ITSEC 2024, Highlighting Versatile ...
Barco is set to showcase its latest advancements in simulation projection technology at I/ITSEC 2024 in Orlando, Florida. The ...
EuropaWire19 小时
Repurposing Drugs to Tackle Antimicrobial Resistance: Insights from University of Helsinki ...
In his doctoral research at the University of Helsinki, Matej Zore demonstrated the potential of repurposing the drugs ...
The Texas Observer16 小时
The Vet, the Cattle Prod, and the ‘Guttural Wail’
An equine surgeon and Texas A&M professor has been convicted of animal cruelty after repeatedly shocking a horse in front of ...
Neos Kosmos18 小时
The old gods, new wars, and the battle for the past
These tattoos might be dismissed as superficial Crusader cosplay, but they rest less comfortably on a man who could command ...
Finanznachrichten21 小时
Anixa Biosciences, Inc.: Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian ...
("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the third cohort in the ...